The FDA Set the Stage for the Opioid Addiction We Have Today

The FDA Set the Stage for the Opioid Addiction We Have Today

#Addiction #opioid #FDA

The US is in the midst of an opioid epidemic and investigators suggest that the Food and Drug Administration (FDA) aided and abetted such a thing to happen from the beginning.

Looking at clinical data from Ys 1997 to 2018, researchers found that, of 48 proposed pain products, none had trials that lasted more than 3 months. “These trials often excluded patients who could not tolerate the drugs and failed to systematically assess some important and well known opioid-related adverse events,” according to a Johns Hopkins news release.

Not only did the “short and small-scale” trials stack the deck in favor of “finding a medicine safe and effective,” but the use of patients’ “spontaneous” reports on safety issues virtually closed the door on learning whether tolerance levels could occur that would lead to non-medical use of the drugs.

In other words, the FDA did not do its oversight job of asking for longer trial periods with more participants and actual trial data on addictive features of the drugs, thus sending them to market and setting the stage for the epidemic that we have today.

Have a healthy day, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   

Latest posts by Paul Ebeling (see all)